Surgical Strategy in Patients with Atrial Septal Defect and Severe Pulmonary Hypertension

Authors

  • Yang Hyun Cho
  • Tae-Gook Jun
  • Ji-Hyuk Yang
  • Pyo Won Park
  • June Huh
  • I-Seok Kang
  • Heung Jae Lee

DOI:

https://doi.org/10.1532/HSF98.20111085

Abstract

The aim of the study was to review our experience with atrial septal defect (ASD) closure with a fenestrated patch in patients with severe pulmonary hypertension. Between July 2004 and February 2009, 16 patients with isolated ASD underwent closure with a fenestrated patch. All patients had a secundum type ASD and severe pulmonary hypertension. Patients ranged in age from 6 to 57 years (mean ± SD, 34.9 ± 13.5 years). The follow-up period was 9 to 59 months (mean, 34.5 ± 13.1 months). The ranges of preoperative systolic and pulmonary arterial pressures were 63 to 119 mm Hg (mean, 83.8 ± 13.9 mm Hg) and 37 to 77 mm Hg (mean, 51.1 ± 10.1 mm Hg). The ranges of preoperative values for the ratio of the pulmonary flow to the systemic flow and for pulmonary arterial resistance were 1.1 to 2.7 (mean, 1.95 ± 0.5) and 3.9 to 16.7 Wood units (mean, 9.8 ± 2.9 Wood units), respectively. There was no early or late mortality. Tricuspid annuloplasty was performed in 14 patients (87.5%). The peak tricuspid regurgitation gradient and the ratio of the systolic pulmonary artery pressure to the systemic arterial pressure were decreased in all patients. The New York Heart Association class and the grade of tricuspid regurgitation were improved in 13 patients (81.2%) and 15 patients (93.7%), respectively. ASD closure in patients with severe pulmonary hypertension can be performed safely if we create fenestration. Tricuspid annuloplasty and a Cox maze procedure may improve the clinical result. Close observation and follow-up will be needed to validate the long-term benefits.

References

Altoff TF, Knebel F, Panda A, et al. 2008. Long-term follow-up of a fenestrated Amplatzer atrial septal occluder in pulmonary arterial hypertension. Chest 133:283-5.nAttie F, Rosas M, Granados N, Zabal C, Buendia A, Calderon J. 2001. Surgical treatment for secundum atrial septal defects in patients >40 years old. A randomized clinical trial. J Am Coll Cardiol 38:2035-42.nBeghetti M, Galie N. 2009. Eisenmenger syndrome: a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. J Am Coll Cardiol 53:733-40.nBruch L, Winkelmann A, Sonntag S, et al. 2008. Fenestrated occluders for treatment of ASD in elderly patients with pulmonary hypertension and/or right heart failure. J Interv Cardiol 21:44-9.nGault JH, Morrow AG, Gay WA Jr, Ross J Jr. 1968. Atrial septal defect in patients over the age of forty years: clinical and hemodynamic studies and the effects of operation. Circulation 37:261-72.nHirabayashi A, Miyaji K, Akagi T. 2009. Continuous epoprostenol therapy and septal defect closure in a patient with severe pulmonary hypertension. Catheter Cardiovasc Interv 73:688-91.nKonstantinides S, Geibel A, Olschewski M, et al. 1995. A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med 333:469-73.nNath J, Foster E, Heidenreich PA. 2004. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 43:405-9.nSachweh JS, Daebritz SH, Hermanns B, et al. 2006. Hypertensive pulmonary vascular disease in adults with secundum or sinus venosus atrial septal defect. Ann Thorac Surg 81:207-13.nSteele PM, Fuster V, Cohen M, Ritter DG, McGoon DC. 1987. Isolated atrial septal defect with pulmonary vascular obstructive disease—long-term follow-up and prediction of outcome after surgical correction. Circulation 76:1037-42.nToyono M, Krasuski RA, Pettersson GB, Matsumura Y, Yamano T, Shiota T. 2009. Persistent tricuspid regurgitation and its predictor in adults after percutaneous and isolated surgical closure of secundum atrial septal defect. Am J Cardiol 104:856-61.nVogel M, Berger F, Kramer A, Alexi-Meshkishvili V, Lange PE. 1999. Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects. Heart 82:30-3.nWood P. 1958. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. I. Br Med J 2:701-9.nZoghbi WA, Enriquez-Sarano M, Foster E, et al. 2003. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16:777-802.n

Published

2012-04-26

How to Cite

Cho, Y. H., Jun, T.-G., Yang, J.-H., Park, P. W., Huh, J., Kang, I.-S., & Lee, H. J. (2012). Surgical Strategy in Patients with Atrial Septal Defect and Severe Pulmonary Hypertension. The Heart Surgery Forum, 15(2), E111-E115. https://doi.org/10.1532/HSF98.20111085

Issue

Section

Articles

Most read articles by the same author(s)